Cempra Announces Pricing of $25 Million Private Placement

Clinical-stage pharmaceutical company Cempra, which is focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced that it has entered into a securities purchase agreement with a selec... [more]

View complete Fierce Biotech article